BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38647050)

  • 21. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Fontolliet C; Bosman FT; Benhattar J
    Gastroenterology; 2002 Apr; 122(4):1113-21. PubMed ID: 11910361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
    Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
    Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MS-FLAG, a novel real-time signal generation method for methylation-specific PCR.
    Bonanno C; Shehi E; Adlerstein D; Makrigiorgos GM
    Clin Chem; 2007 Dec; 53(12):2119-27. PubMed ID: 17962364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p16-specific reactivation and inhibition of cell migration through demethylation of CpG islands by engineered transcription factors.
    Zhang B; Xiang S; Zhong Q; Yin Y; Gu L; Deng D
    Hum Gene Ther; 2012 Oct; 23(10):1071-81. PubMed ID: 22738793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci.
    Kawasaki T; Ohnishi M; Nosho K; Suemoto Y; Kirkner GJ; Meyerhardt JA; Fuchs CS; Ogino S
    Mod Pathol; 2008 Mar; 21(3):245-55. PubMed ID: 18204436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide DNA methylome variation in two genetically distinct chicken lines using MethylC-seq.
    Li J; Li R; Wang Y; Hu X; Zhao Y; Li L; Feng C; Gu X; Liang F; Lamont SJ; Hu S; Zhou H; Li N
    BMC Genomics; 2015 Oct; 16():851. PubMed ID: 26497311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines.
    Lind GE; Thorstensen L; Løvig T; Meling GI; Hamelin R; Rognum TO; Esteller M; Lothe RA
    Mol Cancer; 2004 Oct; 3():28. PubMed ID: 15476557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.
    Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Grieu F; Watanabe G; Iacopetta B
    Br J Cancer; 2006 Feb; 94(4):593-8. PubMed ID: 16421593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis.
    Lu ZM; Zhou J; Wang X; Guan Z; Bai H; Liu ZJ; Su N; Pan K; Ji J; Deng D
    PLoS One; 2012; 7(4):e35928. PubMed ID: 22558275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.
    McCabe MT; Lee EK; Vertino PM
    Cancer Res; 2009 Jan; 69(1):282-91. PubMed ID: 19118013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repetitive elements and enforced transcriptional repression co-operate to enhance DNA methylation spreading into a promoter CpG-island.
    Zhang Y; Shu J; Si J; Shen L; Estecio MR; Issa JP
    Nucleic Acids Res; 2012 Aug; 40(15):7257-68. PubMed ID: 22600741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.
    Frühwald MC; O'Dorisio MS; Dai Z; Tanner SM; Balster DA; Gao X; Wright FA; Plass C
    Oncogene; 2001 Aug; 20(36):5033-42. PubMed ID: 11526488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
    Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
    J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
    Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
    PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline promoter hypermethylation of tumor suppressor genes in gastric cancer.
    Wu PY; Zhang Z; Wang JM; Guo WW; Xiao N; He Q; Wang YP; Fan YM
    World J Gastroenterol; 2012 Jan; 18(1):70-8. PubMed ID: 22228973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation.
    Kiss NB; Muth A; Andreasson A; Juhlin CC; Geli J; Bäckdahl M; Höög A; Wängberg B; Nilsson O; Ahlman H; Larsson C
    Endocr Relat Cancer; 2013 Feb; 20(1):65-78. PubMed ID: 23154831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
    Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
    Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.